A Phase 1 clinical trial of injectable S-892216 for the treatment of COVID-19
Latest Information Update: 21 Jan 2025
Price :
$35 *
At a glance
- Drugs S 892216 (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
- 21 Jan 2025 New trial record